The Mushroom Japan Approved for Cancer in 1977. FDA Tested It. Big Pharma Buried It.

20 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
???? The Nature’s Lost Vault Book Is Now Available. Learn more: https://naturelostvault.com/book.html

For 2,000 years, Chinese physicians brewed it as a tea to restore vitality and fight lung disease. Japanese oncologists have prescribed it to cancer patients since 1977. The FDA quietly approved clinical trials for it in 2007, and the NIH funded the research with $5.4 million.
Meta-analyses covering more than 8,000 patients showed it improves survival rates by 10 to 20 percent alongside conventional treatment.

Your doctor has almost certainly never mentioned it.

This mushroom grows on dead hardwood logs in every temperate forest on Earth. It costs nothing to forage. It cannot be patented. And that patent problem is precisely why it has never made it into an American treatment protocol, no pharmaceutical company will fund $800 million in clinical infrastructure for a compound that cannot generate monopoly revenue.
This vault opens in Ming Dynasty China, travels through five decades of suppressed peer-reviewed evidence, and lands in the story of an 84-year-old woman told she had three months to live, whose oncologist sent her to a clinical trial instead of a casket.

???? Sources:

- Maehara, Yoshihiko, et al. "Biological Mechanism and Clinical Effect of Protein-Bound Polysaccharide K (KRESTIN®)." Surgery Today 42, no. 1 (2012): 8–28.
- Sakamoto, Junichi, et al. "Efficacy of Adjuvant Immunochemotherapy with Polysaccharide K for Patients with Curatively Resected Colorectal Cancer." Cancer Immunology and Immunotherapy 55, no. 4 (2006): 404–411.
- Oba, Koji, et al. "Efficacy of Adjuvant Immunochemotherapy with Polysaccharide K for Patients with Curative Resections of Gastric Cancer." Cancer Immunology and Immunotherapy 56, no. 6 (2007): 905–911.
- Torkelson, Carolyn J., et al. "Phase 1 Clinical Trial of Trametes versicolor in Women with Breast Cancer." ISRN Oncology (2012): 251632.
- Stamets, Paul. "Trametes versicolor (Turkey Tail Mushrooms) and the Treatment of Breast Cancer." Global Advances in Health and Medicine 1, no. 5 (2012): 20.
- Zhong, Li, et al. "Coriolus Versicolor and Ganoderma Lucidum Related Natural Products as an Adjunct Therapy for Cancers." Frontiers in Pharmacology 10 (2019): 703.
- Kidd, Paris M. "The Use of Mushroom Glucans and Proteoglycans in Cancer Treatment." Alternative Medicine Review 5, no. 1 (2000): 4–27.
- Bastyr University Research Institute. "FDA Approves Bastyr Turkey Tail Trial for Cancer Patients." Bastyr University News, 2012.

#plantmedicine #MedicinalMushrooms #naturalimmunity #cancercare #cancerresearch
Categoria
Oncology
Commenta per primo questo video.

Prossimo